Resultados de la búsqueda 451-460 of 89635 for Cancer
These standards recognize scientific excellence and a multispecialty approach focused on cancer prevention, diagnosis and treatment. Mayo Clinic participates in ...
To evaluate the safety of multi-strain probiotic blend in cancer patients receiving ICIs. To evaluate the clinical outcomes related to IIC, including the ...
Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...
Los procedimientos utilizados para el cáncer del recto pueden incluir los siguientes: Extirpar tumores cancerosos muy pequeños del interior del recto. Si los ...
International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study). Rochester, Minn. This is an international phase III trial, with a ...
... cancer. T cells fight infections and, in some cases, can also kill cancer cells. In this study, some of the patient's T cells will be removed from their ...
... cancer treatments for patients with relapsed/refractory multiple myeloma (RRMM). ... Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria ...
The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer ...
A tubular adenoma is benign, meaning it is not cancer, but over time it has the potential to develop into a type of cancer called adenocarcinoma. Because of ...
Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?